Climb Bio Inc Share Price Today: Live Updates & Key Insights

Climb Bio Inc share price today is $6.15, up -12.46%. The stock opened at $6.91 against the previous close of $6.98, with an intraday high of $7.045 and low of $6.02.

Climb Bio Inc Share Price Chart

Climb Bio Inc

us-stock
To Invest in {{usstockname}}
us-stock

Climb Bio Inc Share Price Performance

$6.15 -0.1246(-12.46%) CLYM at 23 Mar 2026 12:29 PM Biotechnology
Lowest Today 6.02
Highest Today 7.045
Today’s Open 6.91
Prev. Close 6.98
52 Week High 8.04
52 Week Low 1.05
Day’s Range: Low 6.02 High 7.045
52-Week Range: Low 1.05 High 8.04
1 day return -
1 Week return -14.6
1 month return +4.37
3 month return +23.57
6 month return +160.94
1 year return +358.86
3 year return -
5 year return -
10 year return -

Climb Bio Inc Institutional Holdings

Climb Bio Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Climb Bio Inc Fundamentals

Market Cap 416.61 M

PB Ratio 2.0777

PE Ratio 0.0

Enterprise Value 190.85 M

Total Assets 167.74 M

Volume 564974

Climb Bio Inc Company Financials

About Climb Bio Inc & investment objective

Company Information Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases. The company's lead product candidate is the budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug which is in phase 2 clinical trials for the treatment of primary membranous nephropathy and immune thrombocytopenia; and Phase 1b clinical trial indicated for the systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN) and other B-cell mediated diseases. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.

Organisation Biotechnology

Employees 28

Industry Biotechnology

CEO Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Climb Bio Inc FAQs

What is the share price of Climb Bio Inc today?

The current share price of Climb Bio Inc is $6.15.

Can I buy Climb Bio Inc shares in India?

Yes, Indian investors can buy Climb Bio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Climb Bio Inc shares in India?

You can easily invest in Climb Bio Inc shares from India by:

Can I buy fractional shares of Climb Bio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Climb Bio Inc?

Climb Bio Inc has a market cap of $416.61 M.

In which sector does Climb Bio Inc belong?

Climb Bio Inc operates in the Biotechnology sector.

What documents are required to invest in Climb Bio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Climb Bio Inc?

The PE ratio of Climb Bio Inc is N/A and the PB ratio is 2.08.